Sign inJoin waitlistJoin the waitlist

Philomena McAndrew

IM/Hematology/Oncology · Tower Hematology Oncology Medical Group

Credentials: · · · · ·

History

Tower Hematology Oncology Medical Group · Cedars-Sinai
Present

Hematology and Medical Oncology
1981–1984
Internal Medicine
1978–1981
Perelman School of Medicine at the University of Pennsylvania
1974–1978

Research

Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study
Journal of the National Cancer Institute · 2006 · 564 citations
Single-cell and spatial profiling identify three response trajectories to pembrolizumab and radiation therapy in triple negative breast cancer
Cancer Cell · 2024 · 150 citations
Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study
Clinical Cancer Research · 2020 · 60 citations

Heather McArthur
4 papers
RB
Reva Basho
3 papers
AH
Alice Ho
2 papers
Armando Giuliano
2 papers
SK
Scott Karlan
2 papers
Stephen Shiao
2 papers
Alice Chung
1 paper
Alison Conlin
1 paper
Amin Mirhadi
1 paper
AL
Amy Ly
1 paper
Anupama Acheson
1 paper
Brie Chun
1 paper · 1 as a fellow

Clinical trials

Phase II Trial of Pembrolizumab/Chemotherapy With Live Biotherapeutic Product MO-03 in Patients With Early Stage Triple Negative Breast Cancer
Sub-investigator · Not yet recruiting · Phase 2
Yuan Yuan
2026–2035
Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer
Sub-investigator · Recruiting · Phase 2
Cedars-Sinai Medical Center
2025–2032